Pfizer
Clarence R. Manuel is a senior scientist at Pfizer's Viral Vaccines department. Clarence has dedicated their career to researching and developing treatments for heart disease and diabetes. Clarence has worked at the American Heart Association, Einstein-Mount Sinai Diabetes Center, and NYIT's Weill Cornell Medicine, among other institutions. In 2018, they were awarded the American Society for Cell Biology/EMBO Annual Meeting's prestigious "Outstanding Abstract" award.
Clarence R. Manuel has a Doctor of Philosophy (PhD) in Pharmacology from St. John's University, a Masters of Biomedical Science in Pharmacological Sciences from Rutgers New Jersey Medical School, and a Bachelor of Arts (B.A.) in English Language and Literature, General from College of Saint Benedict and Saint John's University. Clarence also has a High School Diploma from St. Benedict's Prep School and a certification from The New York Academy of Sciences in 2016 Science Alliance Leadership Training (SALT).
This person is not in the org chart
This person is not in any teams
Pfizer
614 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.